VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is proud to announce the signing of an international natural psilocybin supply agreement with New Zealand-Based Mātai Medical Research Institute (Mātai), on behalf of the Tū Wairua Project. This agreement marks Optimi's first supply deal to New Zealand, a significant milestone for the company's global expansion efforts.
Under the terms of the agreement, Optimi will provide Mātai with a quantity of its validated GMP Full Spectrum Natural Psilocybin extract. Further, the agreement includes tracked stability of the extract, ensuring the highest standards of GMP quality and compliance.
This follows Optimi's recent announcement that three validation batches of its Natural Psilocybin extract had successfully undergone full release testing, resulting in the issuance of the Certificate of Analysis (COA).
In November 2023, the Tū Wairua project, a collaborative effort involving a diverse array of individuals, whānau (families), community groups, and institutions, convened at Rangiwaho Marae, a tribal meeting place in the Tairāwhiti region of New Zealand. The project team has since designed a clinical trial protocol and secured ethics and regulatory approval for its inaugural clinical study.
Scheduled for mid-2024, the trial, titled "Pilot Study of Psilocybin Administration in Healthy Volunteers within a Marae Setting," aims to evaluate the feasibility, acceptability, and safety of administering psychedelic-assisted therapy to Māori patients in a marae setting. The insights gained from this trial will inform potential future controlled trials involving Māori patients with methamphetamine use disorder.
Bill Ciprick, CEO of Optimi Health, expressed his enthusiasm about the agreement, stating, "We are excited to collaborate with Mātai and the Tū Wairua team on this groundbreaking venture. This agreement marks our entry into a new market and underscores the historical and cultural importance of the work being undertaken by our colleagues in New Zealand to honour and respect the indigenous heritage of the Māori people. This project holds special significance for Optimi, and we are honoured to be part of it."
Dr Patrick McHugh, Community Liaison for Mātai, confirms that the trial will centre on training local clinicians, rongoa (traditional Māori medicine) specialists and marae community members as kaitieki (guides) in psychedelic assisted therapy. Additionally, it will involve integrating the associated kawa and tikanga (cultural practices and protocols) into the therapeutic experience, making this the first trial of its kind in Aotearoa.
“We recognise that, alongside many First Nations peoples, we have a relationship with native flora and fauna as a source of healing and reconnection to our respective indigenous cultural practices,” says Jody Toroa, trustee of Rangiwaho Marae. "Optimi medicines provide the closest natural fungi to the marae’s local, indigenous species, which for Rangiwaho Marae and the Tū Wairua collective, is key to the integrity of the project. Synthetic products, by comparison, are not conducive to our reclaiming of cultural knowledge and customary practice,” says Jody.
In New Zealand, any registered prescriber can apply through the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) for permission to administer an unapproved medicine.
As the only fully equipped Canadian psychedelics pharmaceutical manufacturer, Optimi is well-positioned to meet large-scale demand for GMP psilocybin and MDMA drug products through its 10,000 sq ft cultivation and formulation facility.
For media inquiries, please contact Michael Kydd:
michaelk@optimihealth.ca
902.880.6121
For investor inquiries, please contact:
investors@optimihealth.ca
www.optimihealth.ca
ABOUT OPTIMI (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)
Optimi Health Corp. IS a leading Health Canada licensed psychedelics pharmaceutical manufacturer specializing in controlled substances such as GMP-grade natural psilocybin and MDMA for clinical research purposes and patient access programs, as well as functional mushrooms that focus on the health and wellness markets. Built with the purpose of producing scalable psychedelic formulations for transformational human experiences, the Company’s goal is to be the number one trusted, compassionate supplier of safe and compliant GMP drug candidates throughout the world. Optimi’s products are grown and manufactured at its two facilities comprising a total of 20,000 square feet in Princeton, British Columbia.
ABOUT MATAI MEDICAL RESEARCH INSTITUTE:
Established in October 2020, Mātai is a distinguished not-for-profit research and innovation center located in Gisborne Tairāwhiti, New Zealand. Renowned for its cutting-edge medical imaging facilities, including a state-of-the-art GE 3-Tesla MRI machine and a team of expert researchers, Matai is at the forefront of medical innovation.
ABOUT KAUPAPA TŪ WAIRUA:
The project is an evolving collaboration between a diverse group of individuals, whānau, community groups and institutions.
Organisations involved include:
Rangiwaho Marae
Rua Bioscience
ESR
Manaaki Whenua Landcare Research
University of Auckland
University of Waikato
Mātai Medical Research Institute
Tūranga Health
Io Limited
FORWARD‐LOOKING STATEMENTS
This news release contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, “forward-looking statements”) that relate to Optimi’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result,” “are expected to,” “expects,” “will continue,” “is anticipated,” “anticipates,” “believes,” “estimated,” “intends,” “plans,” “forecast,” “projection,” “strategy,” “objective,” and “outlook”) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. forward-looking statements made in this news release include the proposed use of the proceeds of the Offering. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release.
Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond Optimi’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Optimi undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for Optimi to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.
Neither the Canadian Securities Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.
It's hard for unprofitable space stocks to fight "gravity" when Fed interest rates are too high.
South Florida researchers trying to prevent predatory fish from devouring laboratory-grown coral are grasping at biodegradable straws in an effort to restore what some call the rainforest of the sea. Scientists around the world have been working for years to address the decline of coral reef populations. Just last summer, reef rescue groups in South Florida and the Florida Keys were trying to save coral from rising ocean temperatures.
In February, Demis Hassabis, the CEO of Google's DeepMind AI research lab, warned that throwing increasing amounts of compute at the types of AI algorithms in wide use today could lead to diminishing returns. Getting to the "next level" of AI, as it were, Hassabis said, will instead require fundamental research breakthroughs that yield viable alternatives to today's entrenched approaches. Ex-Tesla engineer George Morgan agrees.
Vinod Khosla is making a new bet on foundation AI model startup Symbolica, which launched today with a $33 million Series A round led by Khosla Ventures.
Sierra Space, one of the space industry’s most valuable private companies, plans to go public within the next 18 months, according to its CEO.
Peter Higgs, the famous physicist who predicted the Higgs boson particle, has passed away at the age of 94. He won the Nobel Prize in 2013 for his research.
Argentina's key agricultural regions will receive rain and a drop in temperatures in the coming days, the Buenos Aires grain exchange said on Wednesday, a combination expected to help curb the spread of an insect that has damaged the country's corn lots. Argentina is the world's third-largest exporter of corn, but the crop's current season is being affected by an unusual boom in leafhoppers, an insect that spreads the corn stunt disease spiroplasma. "Most of the agricultural area will see moderate to heavy rainfall (25 to 75 millimeters)" over the next seven days, the grains exchange said in its weekly crop report.
Molten salt reactors (MSRs) represent a fascinating intersection of nuclear history and modern innovation. The concept of using molten salts as both a coolant and fuel carrier dates back to […]
In a significant escalation of its retaliatory measures against “unfriendly” states amid heightened geopolitical tensions, Russia has seized assets of the agricultural holdings company AgroTerra Group. The move, announced on April 8, 2024, has sent shockwaves through the agricultural sector and raised concerns over food security and international trade relations. President Vladimir Putin’s decree places Dutch-registered firms AgroTerra Investments B.V. and AgroTerra Holdings B.V. under the “temp
The $7.8 billion flagship Ark Innovation ETF has lost 7% year-to-date.
Planet Fitness Inc. (NYSE:PLNT) Founder and CEO Mike Grondahl detailed a history of rampant abuse at the company and alleged it misrepresented its financials during a recent interview with controversial right-wing X user Libs of TikTok. This comes after weeks of calls for boycotts of the brand after the company canceled the membership of a Planet Fitness gym goer after speaking out about a biological male in the women's locker room. Planet Fitness's policy allows gym members to use the locker ro
(Bloomberg) — As utilities race to keep ahead of rising electricity demand, developers have proposed a surge of new power plants across the US — and very few of them would run on fossil fuels.Most Read from BloombergUS Sees Imminent Missile Strike on Israel by Iran, ProxiesUS Slams Strikes on Russia Oil Refineries as Risk to Oil MarketsUS Inflation Refuses to Bend, Fanning Fears It Will StickChinese Cement Maker Halted After 99% Crash in 15 MinutesS&P 500 Hit by Fed-Pivot Rethink and War Jitter
(Bloomberg) — A Chinese cement producer was in the spotlight after it suspended stock trading Wednesday, following a selloff that nearly wiped out all its market value in the final 15 minutes of the previous session.Most Read from BloombergUS Slams Strikes on Russia Oil Refineries as Risk to Oil MarketsChinese Cement Maker Halted After 99% Crash in 15 MinutesBond Trader Places Record Futures Bet on Eve of Inflation DataApple’s India iPhone Output Hits $14 Billion in China ShiftUS Core CPI Tops
“I literally saw people jumping on the pieces of the airplane to get them to align."
Managing your taxes can be one of the most complex aspects of estate planning and a new IRS rule change continues that trend. The rule, published at the end of March, changes how the step-up in basis applies to assets held in an irrevocable trust. If you need help interpreting the IRS rule change or setting […] The post Want to Leave Assets to Heirs? IRS Rule Change Should Have You Rethinking Your Irrevocable Trust appeared first on SmartReads CMS – SmartAsset.
Trump Media’s latest challenge is a bid by two co-founders of its Truth Social platform to be allowed to sell their stock in their company before the lockup period expires.
Bill Gross just tweeted he loves these 3 MLPs.
Costco is making $100 million to $200 million a month by selling gold bars, according to a Wells Fargo equity research note.
Precious metals become big business for big-box retailer.
Rent the Runway (RENT) delivered earnings and revenue surprises of -0.52% and 1.75%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?